Lv5
1006 积分 2022-02-22 加入
JSH practical guidelines for hematological malignancies, 2023: leukemia-4. Chronic myeloid leukemia (CML)/myeloproliferative neoplasms (MPN)
10天前
已完结
JSH guideline for tumors of hematopoietic and lymphoid tissues-lukemia: 4. Chronic myelogenous leukemia (CML)/myeloproliferative neoplasms (MPN)
10天前
已完结
Acute lymphoblastic leukaemia
12天前
已完结
Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1+ acute lymphoblastic leukemia
12天前
已完结
Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1+ acute lymphoblastic leukemia
12天前
已关闭
Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1+ acute lymphoblastic leukemia
12天前
已关闭
Ponatinib‐review of historical development, current status, and future research
12天前
已完结
Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment Strategies
13天前
已完结
A safety review of tyrosine kinase inhibitors for chronic myeloid leukemia
14天前
已完结
ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia
15天前
已完结
皖公网安备34019202002308
